Table of Contents

• 1.   Market Introduction
  •   1. Objectives of the Study
      2. Market Definition
      3. Market Scope
       3.1 . Years Considered for the Study
       3.2 . Market Covered
      4. Currency
      5. Limitations
      6. Stakeholders
    
• 2.   Research Methodology
  •   1. Research Data
       1.1 . Secondary Data
        1.1.1 . Key Data from Secondary Sources
       1.2 . Primary Data
        1.2.1. Key Data from Primary Sources
      2. Market Size Estimation
      3. Market Breakdown and Data Triangulation
      4. Assumptions for the Study
    
• 3.   Executive Summary

  •   1. Market Outlook
      2. Segment Outlook
      3. Competitive Insights

• 4.  U.S. Autotransfusion Services Market Variables, Trends & Scope

  •   1. Market Lineage Outlook
      2. Penetration and Growth Prospect Mapping
      3. Industry Value Chain Analysis
      4. Cost Analysis Breakdown
      5. Application Overview
      6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

• 5.  Market Overview

  •  1. Market Dynamics
         1.1. Market Driver Analysis
            1.1.1. Increasing focus of U.S. Autotransfusion Services Market Companies on Brand Protection
            1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
            1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
            1.3.1. Presence of Ambiguous Regulatory Framework

• 6.  U.S. Autotransfusion Services Market Analysis Tools

  •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
      2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Application Landscape
         2.5. Legal Landscape
      3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Application Collaborations
         3.5. Strategic Divestments
      4. Market Entry Strategies
      5. Case Studies

• 7.  U.S. Autotransfusion Services Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)

  • 1. Cardiovascular
    2. Neurology
    3. Orthopedics
    4. Gynecology
    5. Urology
    6. Trauma
    7. Others

• 8.  U.S. Autotransfusion Services Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)

  • 1. Hospitals
    2. Ambulatory Surgery Centers

• 9.  Market Share Analysis and Competitive Landscape

  • 1. Market Landscape - Key Players, Revenue and Presence
    2. Market Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    3. Emerging Companies
    4. U.S. - Market Share Analysis and Key Regional Players
    5. Key Player - Growth Matrix

• 10.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

  •          1. Comprehensive Care Services
                1.1. Company Overview
                1.2. Product Portfolio
                1.3. SWOT Analysis
                1.4. Financial Overview
                1.5. Strategic Overview
             2. SpecialtyCare
                2.1. Company Overview
                2.2. Product Portfolio
                2.3. SWOT Analysis
                2.4. Financial Overview
                2.5. Strategic Overview
            3. Keystone Perfusion
                3.1. Company Overview
                3.2. Product Portfolio
                3.3. SWOT Analysis
                3.4. Financial Overview
                3.5. Strategic Overview
           4. Atlanta Surgical Services Inc.
                4.1. Company Overview
                4.2. Product Portfolio
                4.3. SWOT Analysis
                4.4. Financial Overview
                4.5. Strategic Overview
            5. Vivacity Perfusion
                5.1. Company Overview
                5.2. Product Portfolio
                5.3. SWOT Analysis
                5.4. Financial Overview
                5.5. Strategic Overview
            6. Carolina Autotransfusion, Inc.
               6. 1. Company Overview
               6. 2. Product Portfolio
               6. 3. SWOT Analysis
               6. 4. Financial Overview
               6.5. Strategic Overview
            7. CENTRAL VALLEY PERFUSION, INC.
                7.1. Company Overview
                7.2. Product Portfolio
                7.3. SWOT Analysis
                7.4. Financial Overview
                7.5. Strategic Overview

• 11.  Pre and Post COVID-19 Impact

  • 1. Positive influence on the healthcare industry
    2. The financial disruption of the manufacturing sector
    3. Impact of COVID-19 on emerging companies
    4. Significant mandates in the healthcare regulations initiated by administrations
    5. The overall economic slowdown of the developing and developed nations

• 12.  FutureWise SME Key Takeaway Points for Client

  •